Triploidy is a condition in which an individual has an extra set of chromosomes, which amount to 69 chromosomes in each cell. This may be caused when an egg is fertilized by two sperm or if the sperm or egg has a full set of chromosomes before fertilization. Triploidy occurs in 1-2% of all conceptions, and is fatal to the infant. Most individuals with triploidy are miscarried in early pregnancies or die before or right after birth. Triploidy cannot be treated or cured because of the fatality rate of the disease. Infants who survive after birth have severe birth defects and only live for a few days. Triploidy is not genetic and has no risk factors, but can be diagnosed through a karyotype.
Triploidy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Triploidy below!
For more information on how to use Laverne, please read the How to Guide.
We have 1944 products for the study of Triploidy that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Triploidy is also known as triploidy, chromosome triploidy syndrome, triploidy syndrome, triploid syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.